Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-11

FDA Approved: TESTOSTERONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Lupin Pharmaceuticals' supplemental application for TESTOSTERONE, updating labeling for the generic testosterone product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)